Some high ranked targets like CYP3A4 also are affected by Troglitazone, nevertheless, the activity of CYP2D6 shared by 24 heart disease related drugs is affected only by Rosiglitazone, it was not found in the Troglitazone related targets. This evidence concerns the gene CYP3A4 and heart disorder.